This announcement is a separate document:
トレイダーズホールディングス:CVCファンドを通じ、iPS細胞技術によるiPS創薬・再生医療の研究開発を行う「リジェネフロ株式会社」へ出資
Traders Holdings: Invest in “Rege Nephro Co., Ltd.,” which conducts research and development of iPS drug discovery and regenerative medicine using iPS cell technology through the CVC Fund
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.